Serum levels of carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen and laminin P1 in Duchenne muscular dystrophy

Acta Paediatrica, International Journal of Paediatrics

Volumn 86, Issue 4, 1997, Pages 377-380

  Von Moers, A ^a,b   Danne, T ^a   Moller P ^a   Scheffner, D ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Duchenne muscular dystrophy; extracellular matrix; fibrosis; procollagen I; procollagen III

Indexed keywords

LAMININ; PROCOLLAGEN;

ADOLESCENT; ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BECKER MUSCULAR DYSTROPHY; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; EXTRACELLULAR MATRIX; HUMAN; MYOFIBROSIS; PRIORITY JOURNAL;

EID: 0030966072     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1997.tb09026.x     Document Type: Article

References (27)

1. Engel AG, Yamamoto M, Fischbeck KH. Dystrophinopathies. In: Engel AG, Franzini- Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill Inc., 1994: 1133-87
2. Monaco AP, Neve RL, Colletti-Feener C, Berlelson CJ, Kurnit DM, Kunkel LM. Isolation of a candidate cDNAs for portions of the Duchenne muscular dystrophy gene Nature 1986; 323: 646-50
3. Hofman EP, Brown RH, Kunkel LM. Dystrophin, the protein product of the Duchenne muscular dystrophin locus. Cell 1987; 51: 919-28
4. Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AHM, Belfall B, Klamut HJ, et al. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 1988; 333: 466-9
5. Ervasti JM, Campbell KP. Membrane organisation of the Dystrophin-Glycoprotein complex. Cell 1991; 66: 1121-31
6. Ervasti JM, Campbell KP. Dystrophin and the membrane skeleton. Curr Opin Cell Biol; 5: 82-7
7. Ibraghimor-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoprotein linking to the extracellular matrix. Nature 1992; 355: 696-702
8. Arahata K, Ishiura S, Ishiguro T, Tsukahara T, Nonaka J, Ozawa E, et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 1988; 333: 861-3
9. McArdle A, Edwards RHT, Jackson MJ. How does dystrophin deficiency lead to muscle degeneration? Evidence from mdx mouse. Neuromusc Disord 1995; 5/6: 445-56
10. Brennan JE, Clao DS, Honhui X, Aldape K, Bredt DS. Nitrit Oxide synthase complexed with and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995; 82: 743-52
11. Stephens HR, Duance VC, Dunn MJ, Bailey AJ, Dubowitz V. Collagen types in neuromuscular diseases. J Neurol Sci 1982; 53: 45-62
12. D'Amore PA, Brown RH, Ku PT, Hoffman EP, Watanabe H, Arahata K, et al. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann Neurol 1994; 35: 362-5
13. DiMario J, Buffinger N, Yamada S, Strohmann RC. Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. Science 1989; 244: 688-90
14. Bernasconi P, Torchiana E, Confalonieri P, Brugnoni R, Barresi R, Mora M, et al. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J Clin Invest 1995; 96: 1137-44
15. Goldspink G, Fernandes K, Williams PE, Wells DJ. Age-related changes in collagen gene expression in the msucles of mdx dystrophic and normal mice. Neuromusc Disord 1994; 3/4: 183-91
16. Moers A v, Möller P, Herbst H, Schuppan D, Hübner C. Expression of mRNA of procollagen type I and procollagen type IV and ist cellular localisation in spinal muscular atrophy and Duchenne muscular dystrophy. Neuromuscul Disord 1996; 3/4 Suppl: 34
17. Hayashi YK, Engvall E, Arikawa - Mirasawa E, Goto K, Koga R, Nouaka J. Abnormal localisation of laminin subunits in muscular dystrophies. J. Neurol Sci 1993; 119: 53-64
18. Danne Th, Grüters A, Schuppan D, Quandas N, Enders J, Weber B. Procollagen type III propeptide related antigens in serum reflect somatic growth in healthy children and patients with growth disorders. J Pediatr 1989; 109: 257-60
19. Saggese G, Bertelloni S, Baroncelli GI, Di Nero G. Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from the first year of life to adulthood and in metabolic bone disease. Eur J Pediatr 1992; 151: 764-8
20. Trivedi P, Hindmarsh P, Risteli J, Risteli L, Mowat AP, Brook CGD. Growth velocity, growth hormone therapy and serum concentrations of the amino-terminal propeptide of the type III procollagen. J Pediatr 1989; 114: 225-30
21. Brocks DG, Strecker H, Neubauer HP, Timpl R. Radioimmunoassay of laminin in serum and its application to cancer patients. Clin Chem 1986; 32: 787-91
22. Danne T. Untersuchungen zum Stoffwechsel der extracellulären Matrix im Kindes-alter-mit besonderer Berücksichtigung des Diabetes mellitus. Habilitationsschrift Freie Universität Berlin 1995: 65-75
23. Sorva A, Tähtelä R, Risteli J, Risteli L, Laitinen K, Juntunen-Backmann K, et al. Familial high serum concentrations of the carboxy-terminal propeptide type I procollagen. Clin Chem 1994; 40/8: 1591
24. Kauppila A, Puistola U, Risteli J, Risteli L. Aminoterminal propeptide of type III procollagen: a new prognostic indicator in human ovarian cancer. Cancer Res 1989; 49: 1885-9
25. Schuppan D, Stölzel U, Oesterluig C, Somasundaram R. Serum essays for liver fibrosis. J. Hepatol 1995; 22 Suppl 2: 82-8
26. Smedsrød B. Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells. Collagen. Relat Res 1988; 8: 375-88
27. Smedsrød B, Melkko J, Risteli L, Risteli J. Circulating carboxyterminal propeptide of type I procollagen is cleared mainly via the mannose receptor of liver endothelial cells. Biochemistry 1990; 271: 345-50